Literature DB >> 9344008

Spinal leptomeningeal hemangioblastomatosis in von Hippel-Lindau disease: magnetic resonance and pathological findings.

R Bakshi1, L L Mechtler, M J Patel, B D Lindsay, S Messinger, K J Gibbons.   

Abstract

A 55-year-old man with von Hippel-Lindau disease presented with quadriparesis. Multiple enhancing cervical and thoracic spinal masses were seen on magnetic resonance imaging (MRI). A rim of diffuse, nodular enhancement linking all of the discrete masses was apparent on the surface of the cervical and thoracic regions of the cord. Surgical exploration revealed multiple extramedullary-intradural and intramedullary masses, extending to and infiltrating the cord; the leptomeninges contained numerous small tumor seeds at several levels. The excised spinal masses were diagnosed as capillary hemangioblastomas, which infiltrated the pia mater. Diffuse, intense, spinal leptomeningeal enhancement on MRI associated with multiple hemangioblastomas has not been previously reported and may be referred to as spinal "leptomeningeal hemangioblastomatosis."

Entities:  

Mesh:

Year:  1997        PMID: 9344008     DOI: 10.1111/jon199774242

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  7 in total

1.  Sporadic CNS hemangioblastomatosis, response to sunitinib and secondary polycythemia.

Authors:  German Reyes-Botero; Jaime Gállego Pérez-Larraya; Jaime Gallego Pérez-Larraya; Marc Sanson
Journal:  J Neurooncol       Date:  2011-11-11       Impact factor: 4.130

Review 2.  Hemangioblastomas of the lower spinal region: report of four cases with preoperative embolization and review of the literature.

Authors:  Alessandra Biondi; Giuseppe K Ricciardi; Tierry Faillot; Laurent Capelle; Rémy Van Effenterre; Jacques Chiras
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

3.  Hemangioblastomatosis of the central nervous system without von Hippel-Lindau disease: a case report.

Authors:  Masayasu Kato; Naoyuki Ohe; Ayumi Okumura; Jun Shinoda; Asuka Nomura; Taro Shuin; Noboru Sakai
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

4.  Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report.

Authors:  Lisa R Rogers; Patricia LoRusso; Paul Nadler; Ghaus Malik; Anthony Shields; William Kaelin
Journal:  J Neurooncol       Date:  2010-06-04       Impact factor: 4.130

5.  Disseminated Hemangioblastoma of the Central Nervous System without Von Hippel-Lindau Disease.

Authors:  Sun-Yoon Chung; Sin-Soo Jeun; Jae-Hyun Park
Journal:  Brain Tumor Res Treat       Date:  2014-10-31

6.  Disseminated hemangioblastomatosis of the central nervous system without von Hippel-Lindau disease: a case report.

Authors:  Hong-Rae Kim; Yeon-Lim Suh; Jong-Won Kim; Jung-Il Lee
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

Review 7.  Management Strategies and Outcomes for VHL-related Craniospinal Hemangioblastomas.

Authors:  Christ Ordookhanian; Paul E Kaloostian; Samer S Ghostine; Philippe E Spiess; Arnold B Etame
Journal:  J Kidney Cancer VHL       Date:  2017-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.